Pro­duc­tion halt­ed at Ko­re­an phar­ma af­ter reg­u­la­tors find unau­tho­rized ad­di­tives in 13 drugs

Months af­ter the South Ko­re­an phar­ma Vivo­zon was or­dered to re­call and dis­card 13 drugs af­ter vi­o­lat­ing good man­u­fac­tur­ing prac­tice stan­dards, the Min­istry of Food …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER